Advancing beyond the "heart-healthy diet" for peripheral arterial disease

Journal of Vascular Surgery

Volumn 61, Issue 1, 2015, Pages 265-274

  Nosova, Emily V ^a,b   Conte, Michael S ^a,c   Grenon, S Marlene ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VIPERx Laboratory   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; OMEGA 3 FATTY ACID; PYRIDOXINE; UBIDECARENONE; VITAMIN B GROUP;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DASH DIET; DIET; DIET SUPPLEMENTATION; DIETARY INTAKE; DISABILITY; FOOD; FOOD FREEZING; HEALTH PROMOTION; HUMAN; INTERMITTENT CLAUDICATION; LOW CALORY DIET; LOW CARBOHYDRATE DIET; LOW FAT DIET; MEDICAL SOCIETY; MEDITERRANEAN DIET; NUTRIENT; NUTRITION; NUTRITIONAL DEFICIENCY; NUTRITIONAL HEALTH; ORNISH SPECTRUM DIET; PATIENT EDUCATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; SALT INTAKE; SUGAR INTAKE; SURVIVAL; WEIL ANTI INFLAMMATORY DIET; ADVERSE EFFECTS; DIET THERAPY; DIETARY REFERENCE INTAKE; DIETARY SUPPLEMENT; LIFESTYLE; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME;

DIET; DIETARY SUPPLEMENTS; HUMANS; LIFE STYLE; NUTRITIONAL STATUS; PERIPHERAL ARTERIAL DISEASE; RECOMMENDED DIETARY ALLOWANCES; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 84919372692     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.10.022     Document Type: Review

References (85)

1. I. Tabas, and C.K. Glass Anti-inflammatory therapy in chronic disease: challenges and opportunities Science 339 2013 166 172
2. P.C. Calder Inflammation: an introduction M.L. Garg, L.G. Wood, Nutrition and physical activity in inflammatory diseases 2013 CABI International Oxfordshire, UK 1 22
3. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, J.G. Regensteiner, M.A. Creager, and J.W. Olin Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 2001 1317 1324
4. F.G. Fowkes, D. Rudan, I. Rudan, V. Aboyans, J.O. Denenberg, and M.M. McDermott Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 2013 1329 1340
5. G.D. Smith, M.J. Shipley, and G. Rose Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study Circulation 82 1990 1925 1931
6. G.C. Leng, A.J. Lee, F.G. Fowkes, M. Whiteman, J. Dunbar, and E. Housley Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population Int J Epidemiol 25 1996 1172 1181
7. M.H. Criqui, R.D. Langer, A. Fronek, H.S. Feigelson, M.R. Klaube, and T.J. McCann Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
8. A. Kazmers, A.J. Perkins, and L.A. Jacobs Major lower extremity amputation in Veterans Affairs medical centers Ann Vasc Surg 14 2000 216 222
9. J. Dormandy, L. Heeck, and S. Vig The fate of patients with critical leg ischemia Semin Vasc Surg 12 1999 142 147
10. G. Cotter, C.P. Cannon, C.H. McCabe, Y. Michowitz, E. Kaluski, and A. Charlesworth Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J 145 2003 622 627
11. B.A. Golomb, T.T. Dang, and M.H. Criqui Peripheral arterial disease: morbidity and mortality implications Circulation 114 2006 688 699
12. S.M. Grenon, C.D. Owens, H. Alley, K. Chong, P.K. Yen, and W. Harris n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial Vasc Med 18 2013 263 274
13. P.E. Norman, J.W. Eikelboom, and G.J. Hankey Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications Med J Aust 181 2004 150 154
14. E.M. Mahoney, K. Wang, D.J. Cohen, A.T. Hirsch, M.J. Alberts, and K. Eagle One-year costs in patients with a history of or at risk for atherothrombosis in the United States Circ Cardiovasc Qual Outcomes 1 2008 38 45
15. H. Flu, J.H. van der Hage, B. Knippenberg, J.W. Merkus, J.F. Hamming, and J.W. Lardenoye Treatment for peripheral arterial obstructive disease: an appraisal of the economic outcome of complications J Vasc Surg 48 2008 368 376
16. D.P. Brostow, A.T. Hirsch, T.C. Collins, and M.S. Kurzer The role of nutrition and body composition in peripheral arterial disease Nat Rev Cardiol 9 2012 634 643
17. D. Bunout, M. Petermann, S. Hirsch, P. de la Maza, M. Suazo, and G. Barrera Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls Nutrition 16 2000 434 438
18. E. Ciccarone, A. Di Castelnuovo, M. Salcuni, A. Siani, A. Giacco, and M.B. Donati A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes J Thromb Haemost 1 2003 1744 1752
19. P.T. Donnan, M. Thomson, F.G. Fowkes, R.J. Prescott, and E. Housley Diet as a risk factor for peripheral arterial disease in the general population: the Edinburgh Artery Study Am J Clin Nutr 57 1993 917 921
20. K. Klipstein-Grobusch, J.H. den Breeijen, D.E. Grobbee, H. Boeing, A. Hofman, and J.C. Witteman Dietary antioxidants and peripheral arterial disease: the Rotterdam Study Am J Epidemiol 154 2001 145 149
21. J.S. Lane, C.P. Magno, K.T. Lane, T. Chan, D.B. Hoyt, and S. Greenfield Nutrition impacts the prevalence of peripheral arterial disease in the United States J Vasc Surg 48 2008 897 904
22. G.C. Leng, D.F. Horrobin, F.G. Fowkes, F.B. Smith, G.D. Lowe, and P.T. Donnan Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study Arterioscler Thromb 14 1994 471 478
23. M.E. Tornwall, J. Virtamo, J.K. Haukka, A. Aro, D. Albanes, and J.K. Huttunen Prospective study of diet, lifestyle, and intermittent claudication in male smokers Am J Epidemiol 151 2000 892 901
24. P.E. Norman, and J.T. Powell Vitamin D and cardiovascular disease Circ Res 114 2014 379 393
25. J.J. Carrero, and R.F. Grimble Does nutrition have a role in peripheral vascular disease? Br J Nutr 95 2006 217 229
26. R.H. Eckel, J.M. Jakicic, J.D. Ard, V.S. Hubbard, J.M. de Jesus, and I.M. Lee 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25 suppl 2 2014 S76 99
27. A. Heather, and K. McGrath Cardiovascular disease and inflammation M.L. Garg, L.G. Wood, Nutrition and physical activity in inflammatory diseases 2013 CABI International Oxfordshire, UK 243 259
28. S.M. Grenon, E. Vittinghoff, C.D. Owens, M.S. Conte, M. Whooley, and B.E. Cohen Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study Vasc Med 18 2013 176 184
29. R. Chowdhury, S. Warnakula, S. Kunutsor, F. Crowe, H.A. Ward, and L. Johnson Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis Ann Intern Med 160 2014 398 406
30. P.W. Siri-Tarino, Q. Sun, F.B. Hu, and R.M. Krauss Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease Am J Clin Nutr 91 2010 535 546
31. A.W. Gardner, B.C. Bright, K.A. Ort, and P.S. Montgomery Dietary intake of participants with peripheral artery disease and claudication Angiology 62 2011 270 275
32. R. Antonelli-Incalzi, C. Pedone, M.M. McDermott, S. Bandinelli, B. Miniati, and R.M. Lova Association between nutrient intake and peripheral artery disease: results from the InCHIANTI study Atherosclerosis 186 2006 200 206
33. A.Z. Naqvi, R.B. Davis, and K.J. Mukamal Nutrient intake and peripheral artery disease in adults: key considerations in cross-sectional studies Clin Nutr 33 2014 443 447
34. S. Eilat-Adar, T. Sinai, C. Yosefy, and Y. Henkin Nutritional recommendations for cardiovascular disease prevention Nutrients 5 2013 3646 3683
35. J. Madden, A. Brunner, N.D. Dastur, R.M. Tan, G.B. Nash, and G.E. Rainger Fish oil induced increase in walking distance, but not ankle brachial pressure index, in peripheral arterial disease is dependent on both body mass index and inflammatory genotype Prostaglandins Leukot Essent Fatty Acids 76 2007 331 340
36. E.W. Holy, M. Forestier, E.K. Richter, A. Akhmedov, F. Leiber, and G.G. Camici Dietary alpha-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation Arterioscler Thromb Vasc Biol 31 2011 1772 1780
37. M. Casula, D. Soranna, A.L. Catapano, and G. Corrao Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: a meta-analysis of randomized, double blind, placebo controlled trials Atheroscler Suppl 14 2013 243 251
38. E.C. Rizos, E.E. Ntzani, E. Bika, M.S. Kostapanos, and M.S. Elisaf Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis JAMA 308 2012 1024 1033
39. S. Kotwal, M. Jun, D. Sullivan, V. Perkovic, and B. Neal Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis Circ Cardiovasc Qual Outcomes 5 2012 808 818
40. M.C. Roncaglioni, M. Tombesi, F. Avanzini, S. Barlera, V. Caimi, and P. Longoni n-3 fatty acids in patients with multiple cardiovascular risk factors N Engl J Med 368 2013 1800 1808
41. S.M. Grenon, M. Hughes-Fulford, J. Rapp, and M.S. Conte Polyunsaturated fatty acids and peripheral artery disease Vasc Med 17 2012 51 63
42. S.M. Grenon, J. Aguado-Zuniga, J.P. Hatton, C.D. Owens, M.S. Conte, and M. Hughes-Fulford Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion J Surg Res 177 2012 e35 43
43. P. Yaqoob, and S.R. Shaikh The nutritional and clinical significance of lipid rafts Current opinion in clinical nutrition and metabolic care 13 2010 156 166
44. M. Spite, J. Claria, and C.N. Serhan Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases Cell Metab 19 2014 21 36
45. C.N. Serhan, N. Chiang, and T.E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat Rev Immunol 8 2008 349 361
46. S.M. Grenon, C. Owens, H.F. Alley, K.C. Chong, P. Yen, and W.J. Boscardin Short-term, high-dose fish oil supplementation increases the production of downstream n-3 fatty acid metabolites in patients with peripheral artery disease. ATVB Scientific Sessions 2014 Canada Toronto, Ontario
47. T. Sommerfield, J. Price, and W.R. Hiatt Omega-3 fatty acids for intermittent claudication Cochrane Database Syst Rev 4 2007 CD003833
48. D.R. Leyva, P. Zahradka, B. Ramjiawan, R. Guzman, M. Aliani, and G.N. Pierce The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial Contemp Clin Trials 32 2011 724 730
49. D. Rodriguez-Leyva, W. Weighell, A.L. Edel, R. LaVallee, E. Dibrov, and R. Pinneker Potent antihypertensive action of dietary flaxseed in hypertensive patients Hypertension 62 2013 1081 1089
50. T.A. Mori Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors Food Funct 5 2014 2004 2019
51. H.E. Bays Safety considerations with omega-3 fatty acid therapy Am J Cardiol 99 2007 35 43C
52. P.D. Watson, P.S. Joy, C. Nkonde, S.E. Hessen, and D.G. Karalis Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel - versus - aspirin + clopidogrel in patients with cardiovascular disease Am J Cardiol 104 2009 1052 1054
53. M.R. Malinow, S.S. Kang, L.M. Taylor, P.W. Wong, B. Coull, and T. Inahara Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease Circulation 79 1989 1180 1188
54. F.F. Willems, W.R. Aengevaeren, G.H. Boers, H.J. Blom, and F.W. Verheugt Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease J Am Coll Cardiol 40 2002 766 772
55. R.A. van Dijk, J.A. Rauwerda, M. Steyn, J.W. Twisk, and C.D. Stehouwer Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial Arterioscler Thromb Vasc Biol 21 2001 2072 2079
56. F. Szabo de Edelenyi, A.C. Vergnaud, N. Ahluwalia, C. Julia, S. Hercberg, and J. Blacher Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD Br J Nutr 107 2012 921 927
57. O. Bleie, E. Strand, P.M. Ueland, S.E. Vollset, H. Refsum, and J. Igland Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12 Coron Artery Dis 22 2011 270 278
58. J.L. Anderson, J.L. Halperin, N.M. Albert, B. Bozkurt, R.G. Brindis, and L.H. Curtis Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 2013 1425 1443
59. M.J. Jardine, A. Kang, S. Zoungas, S.D. Navaneethan, T. Ninomiya, and S.U. Nigwekar The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis BMJ 344 2012 e3533
60. C.M. Ulrich, and J.D. Potter Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev 15 2006 189 193
61. A. Oliveria, and C. Lopes Vitamin C, B-Complex Vitamins and Inflammation M.L. Garg, L.G. Wood, Nutrition and physical activity in inflammatory diseases 2013 CABI International Oxfordshire, UK 99 111
62. E.S. Ford, S. Liu, D.M. Mannino, W.H. Giles, and S.J. Smith C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults Eur J Clin Nutr 57 2003 1157 1163
63. S.G. Wannamethee, G.D. Lowe, A. Rumley, K.R. Bruckdorfer, and P.H. Whincup Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis Am J Clin Nutr 83 2006 567 574 quiz 726-7
64. M. Langlois, D. Duprez, J. Delanghe, M. De Buyzere, and D.L. Clement Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis Circulation 103 2001 1863 1868
65. D.H. Lee, A.R. Folsom, L. Harnack, B. Halliwell, and D.R. Jacobs Jr. Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? Am J Clin Nutr 80 2004 1194 1200
66. C.J. Lavie, J.J. Dinicolantonio, R.V. Milani, and J.H. O'Keefe Vitamin D and cardiovascular health Circulation 128 2013 2404 2406
67. L. Wang, Y. Song, J.E. Manson, S. Pilz, W. Marz, and K. Michaelson Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies Circ Cardiovasc Qual Outcomes 5 2012 819 829
68. A.G. Pittas, M. Chung, T. Trikalinos, J. Mitri, M. Brendel, and K. Patel Systematic review: vitamin D and cardiometabolic outcomes Ann Intern Med 152 2010 307 314
69. J.E. Manson, S.S. Bassuk, I.M. Lee, N.R. Cook, M.A. Albert, and D. Gordon The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease Contemp Clin Trials 33 2012 159 171
70. Smith MB, May HT, Blair TL, Anderson JL, Muhlestein JB, Horne BD, et al. Abstract 14699: vitamin D excess is significantly associated with risk of atrial fibrillation. Paper presented at: AHA Scientific Sessions; Nov 2011.
71. J. Kleijnen, and D. Mackerras Vitamin E for intermittent claudication Cochrane Database Syst Rev 2000 CD000987
72. D. Pastori, R. Carnevale, R. Cangemi, M. Saliola, C. Nocella, and S. Bartimoccia Vitamin E serum levels and bleeding risk in patients receiving oral anticoagulant therapy: a retrospective cohort study J Am Heart Assoc 2 2013 e000364
73. L. Gao, Q. Mao, J. Cao, Y. Wang, X. Zhou, and L. Fan Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials Atherosclerosis 221 2012 311 316
74. J.M. Hodgson, G.F. Watts, D.A. Playford, V. Burke, and K.D. Croft Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes Eur J Clin Nutr 56 2002 1137 1142
75. L. Tiano, R. Belardinelli, P. Carnevali, F. Principi, G. Seddaiu, and G.P. Littarru Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study Eur Heart J 28 2007 2249 2255
76. Y.L. Dai, T.H. Luk, K.H. Yiu, M. Wang, P.M. Yip, and S.W. Lee Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial Atherosclerosis 216 2011 395 401
77. M. Wyman, M. Leonard, and T. Morledge Coenzyme Q10: a therapy for hypertension and statin-induced myalgia? Cleve Clin J Med 77 2010 435 442
78. G.C. Leng, A.J. Lee, F.G. Fowkes, R.G. Jepson, G.D. Lowe, and E.R. Skinner Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease Clin Nutr 17 1998 265 271
79. K.D. Conway, and J. Evans A double-blinded, randomized study to determine the effect of omega-3-marine triglycerides on intermittent claudication. Abstract 86 Yearbook 2005 2005 The Vascular Society of Great Britain & Ireland London
80. N.T. Luu, J. Madden, P.C. Calder, R.F. Grimble, C.P. Shearman, and T. Chan Comparison of the pro-inflammatory potential of monocytes from healthy adults and those with peripheral arterial disease using an in vitro culture model Atherosclerosis 193 2007 259 268
81. V. Schiano, E. Laurenzano, G. Brevetti, J.I. De Maio, S. Lanero, and F. Scopacasa Omega-3 polyunsaturated fatty acid in peripher al arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function Clin Nutr 27 2008 241 247
82. J. Madden, C.P. Shearman, R.L. Dunn, N.D. Dastur, R.M. Tan, and G.B. Nash Altered monocyte CD44 expression in peripheral arterial disease is corrected by fish oil supplementation Nutr Metab Cardiovasc Dis 19 2009 247 252
83. M.R. Flock, A.C. Skulas-Ray, W.S. Harris, T.D. Etherton, J.A. Fleming, and P.M. Kris-Etherton Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial J Am Heart Assoc 2 2013 e000513
84. A. Singhal, J. Lanigan, C. Storry, S. Low, T. Birbara, and A. Lucas Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adults J Am Heart Assoc 2 2013 e000283
85. M. Ruiz-Canela, R. Estruch, D. Corella, J. Salas-Salvado, and M.A. Martinez-Gonzalez Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial JAMA 311 2014 415 417